139 related articles for article (PubMed ID: 23424776)
41. miR-183 as a molecular and protective biomarker for cancer in schizophrenic subjects.
Rizos E; Siafakas N; Koumarianou A; Katsantoni E; Filippopoulou A; Ntounas P; Touloumis Ch; Kastania A; Zoumpourlis V
Oncol Rep; 2012 Dec; 28(6):2200-4. PubMed ID: 23007659
[TBL] [Abstract][Full Text] [Related]
42. MicroRNA profiling in migraine without aura: pilot study.
Tafuri E; Santovito D; de Nardis V; Marcantonio P; Paganelli C; Affaitati G; Bucci M; Mezzetti A; Giamberardino MA; Cipollone F
Ann Med; 2015; 47(6):468-73. PubMed ID: 26333279
[TBL] [Abstract][Full Text] [Related]
43. MicroRNA signatures in total peripheral blood of gallbladder cancer patients.
Li G; Pu Y
Tumour Biol; 2015 Sep; 36(9):6985-90. PubMed ID: 25861754
[TBL] [Abstract][Full Text] [Related]
44. MicroRNAs miR-21a and miR-93 are down regulated in peripheral blood mononuclear cells (PBMCs) from patients with type 1 diabetes.
Salas-Pérez F; Codner E; Valencia E; Pizarro C; Carrasco E; Pérez-Bravo F
Immunobiology; 2013 May; 218(5):733-7. PubMed ID: 22999472
[TBL] [Abstract][Full Text] [Related]
45. Immunosenescence-associated microRNAs in age and heart failure.
Seeger T; Haffez F; Fischer A; Koehl U; Leistner DM; Seeger FH; Boon RA; Zeiher AM; Dimmeler S
Eur J Heart Fail; 2013 Apr; 15(4):385-93. PubMed ID: 23258801
[TBL] [Abstract][Full Text] [Related]
46. Circulating Serum MicroRNA-130a as a Novel Putative Marker of Extramedullary Myeloma.
Besse L; Sedlarikova L; Kryukov F; Nekvindova J; Radova L; Slaby O; Kuglik P; Almasi M; Penka M; Krejci M; Adam Z; Pour L; Sevcikova S; Hajek R
PLoS One; 2015; 10(9):e0137294. PubMed ID: 26389804
[TBL] [Abstract][Full Text] [Related]
47. Potential relationship and clinical significance of miRNAs and Th17 cytokines in patients with multiple myeloma.
Li Y; Li D; Yan Z; Qi K; Chen L; Zhang Z; Fan G; Li H; Xu K; Li Z
Leuk Res; 2014 Sep; 38(9):1130-5. PubMed ID: 25092124
[TBL] [Abstract][Full Text] [Related]
48. Downregulation of specific miRNAs in hyperdiploid multiple myeloma mimics the oncogenic effect of IgH translocations occurring in the non-hyperdiploid subtype.
Rio-Machin A; Ferreira BI; Henry T; Gómez-López G; Agirre X; Alvarez S; Rodriguez-Perales S; Prosper F; Calasanz MJ; Martínez J; Fonseca R; Cigudosa JC
Leukemia; 2013 Apr; 27(4):925-31. PubMed ID: 23174883
[TBL] [Abstract][Full Text] [Related]
49. Expression of Peripheral Blood miRNA-720 and miRNA-1246 Can Be Used as a Predictor for Outcome in Multiple Myeloma Patients.
Ren Y; Li X; Wang W; He W; Wang J; Wang Y
Clin Lymphoma Myeloma Leuk; 2017 Jul; 17(7):415-423. PubMed ID: 28601493
[TBL] [Abstract][Full Text] [Related]
50. A set of specific miRNAs is connected with murine and human gastric cancer.
Shah AA; Leidinger P; Backes C; Keller A; Karpinski P; Sasiadek MM; Blin N; Meese E
Genes Chromosomes Cancer; 2013 Mar; 52(3):237-49. PubMed ID: 23124995
[TBL] [Abstract][Full Text] [Related]
51. Comparative Analysis of miRNA Expression Profiles of Multiple Myeloma with 1q21 Gains and Normal FISH.
Cui Y; Liu Y; Wang D; Liu Y; Liu L; Fang B
Acta Haematol; 2018; 139(2):96-100. PubMed ID: 29402764
[TBL] [Abstract][Full Text] [Related]
52. miRNAs in multiple myeloma--a survival relevant complex regulator of gene expression.
Seckinger A; Meißner T; Moreaux J; Benes V; Hillengass J; Castoldi M; Zimmermann J; Ho AD; Jauch A; Goldschmidt H; Klein B; Hose D
Oncotarget; 2015 Nov; 6(36):39165-83. PubMed ID: 26472281
[TBL] [Abstract][Full Text] [Related]
53. Serum high expression of miR-214 and miR-135b as novel predictor for myeloma bone disease development and prognosis.
Hao M; Zang M; Zhao L; Deng S; Xu Y; Qi F; An G; Qin Y; Sui W; Li F; Yang W; Li Z; Yi S; Zou D; Zhan F; Qiu L
Oncotarget; 2016 Apr; 7(15):19589-600. PubMed ID: 26995755
[TBL] [Abstract][Full Text] [Related]
54. Disentangling the microRNA regulatory milieu in multiple myeloma: integrative genomics analysis outlines mixed miRNA-TF circuits and pathway-derived networks modulated in t(4;14) patients.
Calura E; Bisognin A; Manzoni M; Todoerti K; Taiana E; Sales G; Morgan GJ; Tonon G; Amodio N; Tassone P; Neri A; Agnelli L; Romualdi C; Bortoluzzi S
Oncotarget; 2016 Jan; 7(3):2367-78. PubMed ID: 26496024
[TBL] [Abstract][Full Text] [Related]
55. MicroRNAs in urine are not biomarkers of multiple myeloma.
Sedlaříková L; Bešše L; Novosadová S; Kubaczková V; Radová L; Staník M; Krejčí M; Hájek R; Ševčíková S
J Negat Results Biomed; 2015 Sep; 14():16. PubMed ID: 26399230
[TBL] [Abstract][Full Text] [Related]
56. Let-7, mir-98 and mir-183 as biomarkers for cancer and schizophrenia [corrected].
Rizos E; Siafakas N; Katsantoni E; Skourti E; Salpeas V; Rizos I; Tsoporis JN; Kastania A; Filippopoulou A; Xiros N; Margaritis D; Parker TG; Papageorgiou C; Zoumpourlis V
PLoS One; 2015; 10(4):e0123522. PubMed ID: 25856466
[TBL] [Abstract][Full Text] [Related]
57. Identification of circulating microRNAs as diagnostic biomarkers for use in multiple myeloma.
Jones CI; Zabolotskaya MV; King AJ; Stewart HJ; Horne GA; Chevassut TJ; Newbury SF
Br J Cancer; 2012 Dec; 107(12):1987-96. PubMed ID: 23169280
[TBL] [Abstract][Full Text] [Related]
58. Analysis of plasma microRNA expression profiles revealed different cancer susceptibility in healthy young adult smokers and middle-aged smokers.
Shi B; Gao H; Zhang T; Cui Q
Oncotarget; 2016 Apr; 7(16):21676-85. PubMed ID: 26943588
[TBL] [Abstract][Full Text] [Related]
59. [Screening of bone-related microRNAs in serum of patients with osteogenesis imperfect].
Wang Z; Lu Y; Ren X; Wang Y; Li Z; Xu C; Han J
Sheng Wu Gong Cheng Xue Bao; 2012 Oct; 28(10):1245-52. PubMed ID: 23311139
[TBL] [Abstract][Full Text] [Related]
60. Expression and significance of miR-21 in multiple myeloma patients.
Wang JH; Zhou WW; Liu BX; Man DL; Yang ZD; Liu FR; Shang H
Genet Mol Res; 2016 Jan; 15(1):. PubMed ID: 26909911
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
